Therapeutics for central nervous system disorders
US12091378B2 · kind B2 · utility
0Cited by
0References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 23, 2022 |
| Grant date | Sep 17, 2024 |
| Priority date | — |
| Expiry date | May 23, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides novel compounds, pharmaceutical compositions and methods of preparation and use thereof for treating disease affecting the central nervous system such as multiple sclerosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.